Drug information for NOVOLIN N
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
100 UNITS/ML
Discontinued
INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN
Insulin, Isophane
NOVO NORDISK INC
19065
INJECTABLE; INJECTION
100 UNITS/ML
Over The Counter
(Reference Drug)
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
Insulin, Isophane
NOVO NORDISK INC
19959
2011-01-04 Letter
2010-06-29 Letter
2010-06-29 Letter
2009-07-24 Letter
2009-07-23 Label
2009-06-22 Label
2009-06-18 Letter
2003-04-17 Label
2002-04-15 Letter
2002-04-15 Label
2002-04-11 Letter
2002-04-11 Label
2002-03-11 Letter
2002-03-11 Label
1997-04-16 Review
Drug Adverse Effects information for NOVOLIN N
Role code
Indications
Reaction
# Reports
PS
DIABETES MELLITUS
BLOOD GLUCOSE INCREASED
2
PS
DIABETES MELLITUS
CRANIOCEREBRAL INJURY
5
PS
DIABETES MELLITUS
DIABETIC KETOACIDOSIS
5
PS
DIABETES MELLITUS
DIABETIC NEPHROPATHY
2
PS
DIABETES MELLITUS
HYPERGLYCAEMIA
5
PS
DIABETES MELLITUS
HYPOGLYCAEMIA
5
PS
DIABETES MELLITUS
HYPOGLYCAEMIC UNCONSCIOUSNESS
5
PS
PRODUCT USED FOR UNKNOWN INDICATION
MYOCARDIAL INFARCTION
4
PS
PRODUCT USED FOR UNKNOWN INDICATION
VASCULAR GRAFT
4
PS
TYPE 2 DIABETES MELLITUS
ABDOMINAL DISCOMFORT
3
PS
TYPE 2 DIABETES MELLITUS
ANTI-INSULIN ANTIBODY POSITIVE
2
PS
TYPE 2 DIABETES MELLITUS
DYSPEPSIA
3
PS
TYPE 2 DIABETES MELLITUS
HEADACHE
1
PS
TYPE 2 DIABETES MELLITUS
HYPOGLYCAEMIC COMA
2
PS
TYPE 2 DIABETES MELLITUS
HYPOKALAEMIA
2
PS
TYPE 2 DIABETES MELLITUS
INFECTION
2
PS
TYPE 2 DIABETES MELLITUS
INTENTIONAL OVERDOSE
2
PS
TYPE 2 DIABETES MELLITUS
MYOCARDIAL INFARCTION
1
PS
TYPE 2 DIABETES MELLITUS
NAUSEA
1
PS
TYPE 2 DIABETES MELLITUS
PRURITUS
1
PS
TYPE 2 DIABETES MELLITUS
SKIN MASS
1
PS
TYPE 2 DIABETES MELLITUS
TREMOR
1
PS
TYPE 2 DIABETES MELLITUS
VASCULAR GRAFT
1
SS
DIABETES MELLITUS
CRANIOCEREBRAL INJURY
5
SS
DIABETES MELLITUS
DIABETIC KETOACIDOSIS
5
SS
DIABETES MELLITUS
HYPERGLYCAEMIA
5
SS
DIABETES MELLITUS
HYPOGLYCAEMIA
5
SS
DIABETES MELLITUS
HYPOGLYCAEMIC UNCONSCIOUSNESS
5
SS
TYPE 1 DIABETES MELLITUS
BLOOD GLUCOSE FLUCTUATION
2
SS
TYPE 1 DIABETES MELLITUS
HYPOGLYCAEMIC SEIZURE
2
SS
TYPE 1 DIABETES MELLITUS
HYPOGLYCAEMIC UNCONSCIOUSNESS
2
C
ANTICOAGULANT THERAPY
ANAEMIA
3
C
ANTICOAGULANT THERAPY
FLUID RETENTION
3
C
ANTICOAGULANT THERAPY
HAEMATOCHEZIA
3
C
ANTICOAGULANT THERAPY
HAEMORRHAGE
3
C
ANTICOAGULANT THERAPY
HAEMORRHOIDAL HAEMORRHAGE
3
C
ANTICOAGULANT THERAPY
LOSS OF CONSCIOUSNESS
3
C
ANTICOAGULANT THERAPY
MOUTH HAEMORRHAGE
3
C
ANTICOAGULANT THERAPY
OEDEMA
3
C
ANTICOAGULANT THERAPY
OEDEMA PERIPHERAL
3
C
ANTICOAGULANT THERAPY
PAIN IN EXTREMITY
1
C
ANTICOAGULANT THERAPY
VOMITING
3
C
ATRIAL FIBRILLATION
ANAEMIA
6
C
ATRIAL FIBRILLATION
FLUID RETENTION
6
C
ATRIAL FIBRILLATION
GASTROINTESTINAL HAEMORRHAGE
1
C
ATRIAL FIBRILLATION
HAEMATOCHEZIA
6
C
ATRIAL FIBRILLATION
HAEMORRHAGE
6
C
ATRIAL FIBRILLATION
HAEMORRHOIDAL HAEMORRHAGE
6
C
ATRIAL FIBRILLATION
INTERNATIONAL NORMALISED RATIO INCREASED
1
C
ATRIAL FIBRILLATION
LOSS OF CONSCIOUSNESS
6
C
ATRIAL FIBRILLATION
MOUTH HAEMORRHAGE
6
C
ATRIAL FIBRILLATION
OEDEMA
6
C
ATRIAL FIBRILLATION
OEDEMA PERIPHERAL
6
C
ATRIAL FIBRILLATION
PAIN IN EXTREMITY
2
C
ATRIAL FIBRILLATION
RESPIRATORY FAILURE
1
C
ATRIAL FIBRILLATION
VOMITING
6
C
BLOOD CHOLESTEROL INCREASED
ANAEMIA
6
C
BLOOD CHOLESTEROL INCREASED
FLUID RETENTION
6
C
BLOOD CHOLESTEROL INCREASED
HAEMATOCHEZIA
6
C
BLOOD CHOLESTEROL INCREASED
HAEMORRHAGE
6
C
BLOOD CHOLESTEROL INCREASED
HAEMORRHAGIC STROKE
1
C
BLOOD CHOLESTEROL INCREASED
HAEMORRHOIDAL HAEMORRHAGE
6
C
BLOOD CHOLESTEROL INCREASED
INTRACRANIAL ANEURYSM
1
C
BLOOD CHOLESTEROL INCREASED
LOSS OF CONSCIOUSNESS
6
C
BLOOD CHOLESTEROL INCREASED
MOUTH HAEMORRHAGE
6
C
BLOOD CHOLESTEROL INCREASED
OEDEMA
6
C
BLOOD CHOLESTEROL INCREASED
OEDEMA PERIPHERAL
6
C
BLOOD CHOLESTEROL INCREASED
PAIN IN EXTREMITY
2
C
BLOOD CHOLESTEROL INCREASED
VOMITING
6
C
BLOOD PRESSURE
CORONARY ARTERY BYPASS
2
C
BLOOD PRESSURE
FLUSHING
2
C
BLOOD TRIGLYCERIDES INCREASED
ANAEMIA
3
C
BLOOD TRIGLYCERIDES INCREASED
FLUID RETENTION
3
C
BLOOD TRIGLYCERIDES INCREASED
HAEMATOCHEZIA
3
C
BLOOD TRIGLYCERIDES INCREASED
HAEMORRHAGE
3
C
BLOOD TRIGLYCERIDES INCREASED
HAEMORRHOIDAL HAEMORRHAGE
3
C
BLOOD TRIGLYCERIDES INCREASED
LOSS OF CONSCIOUSNESS
3
C
BLOOD TRIGLYCERIDES INCREASED
MOUTH HAEMORRHAGE
3
C
BLOOD TRIGLYCERIDES INCREASED
OEDEMA
3
C
BLOOD TRIGLYCERIDES INCREASED
OEDEMA PERIPHERAL
3
C
BLOOD TRIGLYCERIDES INCREASED
PAIN IN EXTREMITY
1
C
BLOOD TRIGLYCERIDES INCREASED
VOMITING
3
C
CARDIAC FAILURE
CARDIAC FAILURE ACUTE
20
C
CARDIAC FAILURE
FLUID OVERLOAD
20
C
CARDIAC FAILURE
PULMONARY CONGESTION
20
C
CARDIAC FAILURE CHRONIC
CARDIAC FAILURE ACUTE
3
C
CARDIAC FAILURE CHRONIC
FLUID OVERLOAD
3
C
CARDIAC FAILURE CHRONIC
PULMONARY CONGESTION
3
C
CARDIOVASCULAR DISORDER
VITREOUS HAEMORRHAGE
2
C
CARDIOVASCULAR EVENT PROPHYLAXIS
CORONARY ARTERY BYPASS
1
C
CARDIOVASCULAR EVENT PROPHYLAXIS
FLUSHING
1
C
CAROTID ARTERY STENOSIS
VITREOUS HAEMORRHAGE
2
C
CHEST PAIN
BACK PAIN
2
C
CHEST PAIN
BLOOD PRESSURE DECREASED
2
C
CHEST PAIN
CARDIAC ARREST
2
C
CHEST PAIN
CARDIAC DISORDER
2
C
CHEST PAIN
DYSPNOEA
2
C
CHEST PAIN
LOSS OF CONSCIOUSNESS
2
C
CHEST PAIN
MYOCARDIAL INFARCTION
2
C
CHEST PAIN
ORGAN FAILURE
2
C
CHEST PAIN
RESPIRATORY FAILURE
2
C
CHEST PAIN
SYNCOPE
2
C
CONSTIPATION
CARDIAC FAILURE ACUTE
4
C
CONSTIPATION
FLUID OVERLOAD
4
C
CONSTIPATION
PULMONARY CONGESTION
4
C
CONTRACEPTION
DEEP VEIN THROMBOSIS
3
C
CONTRACEPTION
PAIN
3
C
CORONARY ARTERY BYPASS
ANXIETY
1
C
CORONARY ARTERY BYPASS
EMOTIONAL DISTRESS
1
C
CORONARY ARTERY BYPASS
FEAR
1
C
CORONARY ARTERY BYPASS
PAIN
1
C
CORONARY ARTERY BYPASS
RENAL FAILURE
1
C
CORONARY ARTERY BYPASS
RENAL IMPAIRMENT
1
C
CORONARY ARTERY BYPASS
RENAL INJURY
1
C
CORONARY ARTERY BYPASS
STRESS
1
C
CORONARY ARTERY BYPASS
UNEVALUABLE EVENT
1
C
COUGH
HAEMORRHAGIC STROKE
1
C
COUGH
INTRACRANIAL ANEURYSM
1
C
DIABETES MELLITUS
ABDOMINAL PAIN UPPER
3
C
DIABETES MELLITUS
ANAEMIA
6
C
DIABETES MELLITUS
ANGER
3
C
DIABETES MELLITUS
CARDIAC DISORDER
6
C
DIABETES MELLITUS
CARDIAC FAILURE ACUTE
8
C
DIABETES MELLITUS
CORONARY ARTERY BYPASS
2
C
DIABETES MELLITUS
DIARRHOEA
3
C
DIABETES MELLITUS
DRUG INEFFECTIVE
2
C
DIABETES MELLITUS
DYSPNOEA
3
C
DIABETES MELLITUS
FLUID OVERLOAD
8
C
DIABETES MELLITUS
FLUID RETENTION
6
C
DIABETES MELLITUS
FLUSHING
2
C
DIABETES MELLITUS
HAEMATOCHEZIA
6
C
DIABETES MELLITUS
HAEMORRHAGE
6
C
DIABETES MELLITUS
HAEMORRHAGIC STROKE
3
C
DIABETES MELLITUS
HAEMORRHOIDAL HAEMORRHAGE
6
C
DIABETES MELLITUS
INSOMNIA
3
C
DIABETES MELLITUS
INTRACRANIAL ANEURYSM
3
C
DIABETES MELLITUS
LOSS OF CONSCIOUSNESS
6
C
DIABETES MELLITUS
MOUTH HAEMORRHAGE
6
C
DIABETES MELLITUS
MYOCARDIAL INFARCTION
6
C
DIABETES MELLITUS
OEDEMA
6
C
DIABETES MELLITUS
OEDEMA PERIPHERAL
12
C
DIABETES MELLITUS
ORGANISING PNEUMONIA
1
C
DIABETES MELLITUS
PAIN IN EXTREMITY
2
C
DIABETES MELLITUS
PULMONARY CONGESTION
8
C
DIABETES MELLITUS
RASH
1
C
DIABETES MELLITUS
SUFFOCATION FEELING
6
C
DIABETES MELLITUS
SUICIDAL IDEATION
3
C
DIABETES MELLITUS
VOMITING
6
C
EAR INFECTION
HAEMORRHAGIC STROKE
1
C
EAR INFECTION
INTRACRANIAL ANEURYSM
1
C
EAR PAIN
HAEMORRHAGIC STROKE
1
C
EAR PAIN
INTRACRANIAL ANEURYSM
1
C
GASTRITIS PROPHYLAXIS
CARDIAC FAILURE ACUTE
4
C
GASTRITIS PROPHYLAXIS
FLUID OVERLOAD
4
C
GASTRITIS PROPHYLAXIS
PULMONARY CONGESTION
4
C
GLAUCOMA
VITREOUS HAEMORRHAGE
6
C
GOUT
ABDOMINAL PAIN UPPER
1
C
GOUT
ANGER
1
C
GOUT
DIARRHOEA
1
C
GOUT
DYSPNOEA
1
C
GOUT
INSOMNIA
1
C
GOUT
SUICIDAL IDEATION
1
C
HAEMORRHOIDS
CARDIAC FAILURE ACUTE
4
C
HAEMORRHOIDS
FLUID OVERLOAD
4
C
HAEMORRHOIDS
PULMONARY CONGESTION
4
C
HIGH DENSITY LIPOPROTEIN DECREASED
CORONARY ARTERY BYPASS
1
C
HIGH DENSITY LIPOPROTEIN DECREASED
FLUSHING
1
C
HYPERLIPIDAEMIA
CARDIAC FAILURE ACUTE
4
C
HYPERLIPIDAEMIA
FLUID OVERLOAD
4
C
HYPERLIPIDAEMIA
PULMONARY CONGESTION
4
C
HYPERLIPIDAEMIA
TENDON RUPTURE
1
C
HYPERTENSION
ANAEMIA
18
C
HYPERTENSION
ANGIOGRAM PERIPHERAL
3
C
HYPERTENSION
APATHY
3
C
HYPERTENSION
ARTHRITIS
3
C
HYPERTENSION
BACK PAIN
3
C
HYPERTENSION
BLOOD GLUCOSE FLUCTUATION
3
C
HYPERTENSION
BLOOD GLUCOSE INCREASED
3
C
HYPERTENSION
CLOSTRIDIAL INFECTION
3
C
HYPERTENSION
CYSTITIS
3
C
HYPERTENSION
FLUID RETENTION
18
C
HYPERTENSION
HAEMATOCHEZIA
18
C
HYPERTENSION
HAEMORRHAGE
18
C
HYPERTENSION
HAEMORRHAGIC STROKE
1
C
HYPERTENSION
HAEMORRHOIDAL HAEMORRHAGE
18
C
HYPERTENSION
HEART RATE DECREASED
3
C
HYPERTENSION
HYPERHIDROSIS
3
C
HYPERTENSION
IMPAIRED HEALING
3
C
HYPERTENSION
INTRACRANIAL ANEURYSM
1
C
HYPERTENSION
KNEE OPERATION
3
C
HYPERTENSION
LIMB OPERATION
3
C
HYPERTENSION
LOSS OF CONSCIOUSNESS
18
C
HYPERTENSION
MEMORY IMPAIRMENT
3
C
HYPERTENSION
MOBILITY DECREASED
3
C
HYPERTENSION
MOUTH HAEMORRHAGE
18
C
HYPERTENSION
OEDEMA
18
C
HYPERTENSION
OEDEMA PERIPHERAL
18
C
HYPERTENSION
PAIN IN EXTREMITY
6
C
HYPERTENSION
PNEUMONIA
3
C
HYPERTENSION
PYREXIA
3
C
HYPERTENSION
RHEUMATOID ARTHRITIS
3
C
HYPERTENSION
SPINAL FUSION SURGERY
3
C
HYPERTENSION
THERAPEUTIC REACTION TIME DECREASED
3
C
HYPERTENSION
VITREOUS HAEMORRHAGE
4
C
HYPERTENSION
VOMITING
18
C
HYPERTENSION
WOUND
3
C
HYPERURICAEMIA
CARDIAC FAILURE ACUTE
4
C
HYPERURICAEMIA
FLUID OVERLOAD
4
C
HYPERURICAEMIA
PULMONARY CONGESTION
4
C
HYPOTHYROIDISM
CARDIAC DISORDER
3
C
HYPOTHYROIDISM
DRUG INEFFECTIVE
1
C
HYPOTHYROIDISM
MYOCARDIAL INFARCTION
3
C
HYPOTHYROIDISM
OEDEMA PERIPHERAL
3
C
HYPOTHYROIDISM
SUFFOCATION FEELING
3
C
INSOMNIA
CARDIAC FAILURE ACUTE
4
C
INSOMNIA
FLUID OVERLOAD
4
C
INSOMNIA
PULMONARY CONGESTION
4
C
LOW DENSITY LIPOPROTEIN INCREASED
CORONARY ARTERY BYPASS
1
C
LOW DENSITY LIPOPROTEIN INCREASED
FLUSHING
1
C
MYOCARDIAL INFARCTION
CARDIAC FAILURE ACUTE
8
C
MYOCARDIAL INFARCTION
FLUID OVERLOAD
8
C
MYOCARDIAL INFARCTION
PULMONARY CONGESTION
8
C
PANCREATIC CARCINOMA
CARDIOVASCULAR DISORDER
1
C
PANCREATIC CARCINOMA
DIARRHOEA
1
C
PANCREATIC CARCINOMA
INCORRECT DOSE ADMINISTERED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BACK PAIN
20
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD PRESSURE DECREASED
20
C
PRODUCT USED FOR UNKNOWN INDICATION
CARDIAC ARREST
20
C
PRODUCT USED FOR UNKNOWN INDICATION
CARDIAC DISORDER
41
C
PRODUCT USED FOR UNKNOWN INDICATION
CORONARY ARTERY BYPASS
9
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INEFFECTIVE
7
C
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
20
C
PRODUCT USED FOR UNKNOWN INDICATION
FLUSHING
9
C
PRODUCT USED FOR UNKNOWN INDICATION
HAEMORRHAGIC STROKE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPOGLYCAEMIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
INTRACRANIAL ANEURYSM
1
C
PRODUCT USED FOR UNKNOWN INDICATION
LOSS OF CONSCIOUSNESS
20
C
PRODUCT USED FOR UNKNOWN INDICATION
MYOCARDIAL INFARCTION
41
C
PRODUCT USED FOR UNKNOWN INDICATION
OEDEMA PERIPHERAL
21
C
PRODUCT USED FOR UNKNOWN INDICATION
ORGAN FAILURE
20
C
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY FAILURE
20
C
PRODUCT USED FOR UNKNOWN INDICATION
SUFFOCATION FEELING
21
C
PRODUCT USED FOR UNKNOWN INDICATION
SYNCOPE
20
C
PROPHYLAXIS
ANAEMIA
3
C
PROPHYLAXIS
FLUID RETENTION
3
C
PROPHYLAXIS
HAEMATOCHEZIA
3
C
PROPHYLAXIS
HAEMORRHAGE
3
C
PROPHYLAXIS
HAEMORRHOIDAL HAEMORRHAGE
3
C
PROPHYLAXIS
LOSS OF CONSCIOUSNESS
3
C
PROPHYLAXIS
MOUTH HAEMORRHAGE
3
C
PROPHYLAXIS
OEDEMA
3
C
PROPHYLAXIS
OEDEMA PERIPHERAL
3
C
PROPHYLAXIS
PAIN IN EXTREMITY
1
C
PROPHYLAXIS
VOMITING
3
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
VITREOUS HAEMORRHAGE
2
C
PULMONARY ARTERIAL HYPERTENSION
ATRIAL FIBRILLATION
2
C
PULMONARY ARTERIAL HYPERTENSION
CHEST PAIN
2
C
PULMONARY ARTERIAL HYPERTENSION
DIZZINESS
2
C
RENAL FAILURE CHRONIC
CARDIAC FAILURE ACUTE
12
C
RENAL FAILURE CHRONIC
FLUID OVERLOAD
12
C
RENAL FAILURE CHRONIC
PULMONARY CONGESTION
12
C
RHEUMATOID ARTHRITIS
CARDIAC DISORDER
3
C
RHEUMATOID ARTHRITIS
DRUG INEFFECTIVE
1
C
RHEUMATOID ARTHRITIS
MYOCARDIAL INFARCTION
3
C
RHEUMATOID ARTHRITIS
OEDEMA PERIPHERAL
3
C
RHEUMATOID ARTHRITIS
SUFFOCATION FEELING
3
C
STENT PLACEMENT
ANAEMIA
3
C
STENT PLACEMENT
FLUID RETENTION
3
C
STENT PLACEMENT
HAEMATOCHEZIA
3
C
STENT PLACEMENT
HAEMORRHAGE
3
C
STENT PLACEMENT
HAEMORRHOIDAL HAEMORRHAGE
3
C
STENT PLACEMENT
LOSS OF CONSCIOUSNESS
3
C
STENT PLACEMENT
MOUTH HAEMORRHAGE
3
C
STENT PLACEMENT
OEDEMA
3
C
STENT PLACEMENT
OEDEMA PERIPHERAL
3
C
STENT PLACEMENT
PAIN IN EXTREMITY
1
C
STENT PLACEMENT
VOMITING
3
C
SUPPLEMENTATION THERAPY
CORONARY ARTERY BYPASS
1
C
SUPPLEMENTATION THERAPY
FLUSHING
1
C
TYPE 1 DIABETES MELLITUS
ANIMAL BITE
6
C
TYPE 1 DIABETES MELLITUS
ASTHENIA
5
C
TYPE 1 DIABETES MELLITUS
BLINDNESS UNILATERAL
6
C
TYPE 1 DIABETES MELLITUS
BLOOD GLUCOSE ABNORMAL
5
C
TYPE 1 DIABETES MELLITUS
BLOOD GLUCOSE FLUCTUATION
5
C
TYPE 1 DIABETES MELLITUS
BLOOD GLUCOSE INCREASED
11
C
TYPE 1 DIABETES MELLITUS
DRUG INEFFECTIVE
5
C
TYPE 1 DIABETES MELLITUS
DRUG INTOLERANCE
5
C
TYPE 1 DIABETES MELLITUS
EYE OPERATION
6
C
TYPE 1 DIABETES MELLITUS
FLANK PAIN
5
C
TYPE 1 DIABETES MELLITUS
GLYCOSYLATED HAEMOGLOBIN INCREASED
5
C
TYPE 1 DIABETES MELLITUS
HYPERHIDROSIS
5
C
TYPE 1 DIABETES MELLITUS
INCORRECT DOSE ADMINISTERED
3
C
TYPE 1 DIABETES MELLITUS
PAIN IN EXTREMITY
5
C
TYPE 1 DIABETES MELLITUS
RENAL DISORDER
6
C
TYPE 1 DIABETES MELLITUS
TREMOR
5
C
TYPE 1 DIABETES MELLITUS
VISUAL ACUITY REDUCED
6
C
TYPE 1 DIABETES MELLITUS
VISUAL FIELD DEFECT
6
C
TYPE 1 DIABETES MELLITUS
VISUAL IMPAIRMENT
5
C
TYPE 2 DIABETES MELLITUS
ANGIOGRAM PERIPHERAL
3
C
TYPE 2 DIABETES MELLITUS
APATHY
3
C
TYPE 2 DIABETES MELLITUS
ARTHRITIS
3
C
TYPE 2 DIABETES MELLITUS
BACK PAIN
3
C
TYPE 2 DIABETES MELLITUS
BLOOD GLUCOSE FLUCTUATION
3
C
TYPE 2 DIABETES MELLITUS
BLOOD GLUCOSE INCREASED
3
C
TYPE 2 DIABETES MELLITUS
CLOSTRIDIAL INFECTION
3
C
TYPE 2 DIABETES MELLITUS
CYSTITIS
3
C
TYPE 2 DIABETES MELLITUS
HEART RATE DECREASED
3
C
TYPE 2 DIABETES MELLITUS
HYPERHIDROSIS
3
C
TYPE 2 DIABETES MELLITUS
IMPAIRED HEALING
3
C
TYPE 2 DIABETES MELLITUS
KNEE OPERATION
3
C
TYPE 2 DIABETES MELLITUS
LIMB OPERATION
3
C
TYPE 2 DIABETES MELLITUS
MEMORY IMPAIRMENT
3
C
TYPE 2 DIABETES MELLITUS
MOBILITY DECREASED
3
C
TYPE 2 DIABETES MELLITUS
PNEUMONIA
3
C
TYPE 2 DIABETES MELLITUS
PYREXIA
3
C
TYPE 2 DIABETES MELLITUS
RHEUMATOID ARTHRITIS
3
C
TYPE 2 DIABETES MELLITUS
SPINAL FUSION SURGERY
3
C
TYPE 2 DIABETES MELLITUS
THERAPEUTIC REACTION TIME DECREASED
3
C
TYPE 2 DIABETES MELLITUS
VITREOUS HAEMORRHAGE
4
C
TYPE 2 DIABETES MELLITUS
WOUND
3
Ads by Google